Drug recall · March 6, 2024
Fluticasone Propionate Nasal Spray USP recall
Why: CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: Apotek Inc., Toronto, Ontario, Cananda, Marketed by: GSMS Incorporated, Camarillo, CA, NDC 60429-195-15
- Lots / codes
Lot #: TX5275, Exp. Date: 10/31/2026.
- Quantity
- 59,712 bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- Nationwide in the USA
- Initiated
- February 14, 2024 · Voluntary: Firm initiated
- Classified
- February 23, 2024
- Reported
- March 6, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluticasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.